Canine FaSSIF/FaSSGF
-
Examine how an oral drug will be released from a formulation and dissolve in canine gastrointestinal fluids using rapid and cost effective in vitro studies
- Streamline preclinical development and reduce canine preclinical testing by linking your oral drug's in vitro biorelevant solubility and dissolution to in vivo preclinical canine bioavailability
-
Makes 3 different dissolution media: Canine FaSSIF, Canine FaSSGF (pH 1.5) and Canine FaSSGF (pH 6.5)
Simulate different regions of the canine gastrointestinal tract
Use in combination with K9 Powder
High filtration efficiency with minimal risk of clogging or bursting
Low drug adsorption and negligible extractables
High filtration efficiency with minimal risk of clogging or bursting
Low drug adsorption and negligible extractables
For filtration of dissolution samples <5mL we recommend 13mm version
For filtration of dissolution samples >5mL we recommend 25mm version
We have emailed you the results
Error while sending the email
Please try again
Canine FaSSIF and Canine FaSSGF are dissolution media that simulate fasted canine gut fluids. These in vitro test media contain physiological surfactants (bile salts and lecithin) present in a dog's gastrointestinal tract. There are three different test media that can be made from this product and the corresponding buffer concentrates:
FaSSIF-K9: Canine Fasted State Simulated Intestinal Fluid
FaSSGF-K9 (pH 1.5): Canine Fasted State Simulated Gastric Fluid after administration of pentagastrin (pH 1.5)
FaSSGF-K9 (pH 6.5): Canine Fasted State Simulated Gastric Fluid (pH 6.5)

These media are used during pre-clinical formulation development of NCEs as well as for the development of veterinary products intended for canine companions. The composition of these media is distinct from the equivalent human versions because the higher level of surfactants found in dog intestinal fluid can enhance the dissolution of poorly soluble drugs. This can help you interpret pre-clinical canine drug bioavailability results more effectively and link canine bioavailability results to human bioavailability.
FaSSGF-K9 (pH 6.5) is also quite different from the equivalent human medium because the pH of fasted dog stomach fluid is typically mucb higher than the pH of fasted human gastric fluid. This can significantly influence the canine in vivo absorption of bases compared to humans.
FaSSGF-K9 (pH 1.5) reflects the pH of the canine stomach fluid after co-administration of pentagastrin which is used in preclinical canine studies to encourage the acidification of the stomach fluid. This is important when testing pH sensitive drugs (especially bases) as the lower pH of the fluid can increase the solubility of a drug before it enters the small intestine leading to higher absorption.
These media are described in the recently added ‘USP Chapter <1236> Solubility Measurements’.






























